An overview of sulbactam‐durlobactam approval and implications in advancing therapeutics for hospital‐acquired and ventilator‐associated pneumonia by acinetobacter baumannii‐calcoaceticus complex: A narrative review
2024Health Science ReportsJournalOpen access
10.1002/hsr2.70066Full text11 citations